Ukrain: a novel antitumor drug

Area of Science:

• Pharmacology
• Oncology
• Immunology

Background:

• Ukrain is a thiophosphate derivative of alkaloids from Chelidonium majus L.
• Anticancer drug development is an ongoing area of research.
• Selective cytotoxicity and immune response modification are desirable properties for cancer therapeutics.

Purpose of the Study:

• To review the recent literature on the anticancer drug Ukrain.
• To summarize the properties and potential applications of Ukrain in oncology.

Main Methods:

• Literature review of recent studies on Ukrain.
• Analysis of Ukrain's pharmacological effects, including cytotoxicity, cytostatic activity, and immunomodulatory properties.
• Evaluation of Ukrain's safety profile and side effects.

Main Results:

• Ukrain demonstrates selective cytotoxic and cytostatic effects on tumor cells.
• Ukrain acts as an immune response modifier.
• The drug exhibits good tolerance with a lack of side effects, even after long-term use.

Conclusions:

• Ukrain presents a promising therapeutic option in oncology.
• Its selective action, immune-modulating effects, and favorable safety profile warrant further investigation.
• Future applications of Ukrain in cancer treatment are anticipated.